Cerus Profit Margin

The latest profit margin for CERS is -3.06% as of June 2026. That compares with -9.81% in the prior-year period — up 68.8% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Cerus's historical trend and sector peers before judging valuation or financial health.

Over the past year, CERS's profit margin moved from -9.81% to -3.06% — a 68.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cerus's valuation or profitability profile.

Against Healthcare companies, CERS currently prints -3.06% for profit margin, while the sector average sits near 14.41%. That is roughly 121.2% below the sector mean. Large gaps often invite a closer look at Cerus's growth, margins, and balance sheet.

Profit Margin shows how effectively Cerus converts resources into returns. At -3.06%, CERS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9.81% in the prior-year period — up 68.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CERS's profit margin (-3.06%), review year-over-year change from -9.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.